👤 Saverio Tardito

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
2
Articles
3
Name variants
Also published as: S Tardito, S. Tardito,
articles
S Weigelt, RA Weinberg, S Mei +175 more · 2024 · BMC Cancer · BioMed Central · added 2026-04-20
S Weigelt, RA Weinberg, S Mei, X Chen, K Wang, Y Chen, N Colombo, C Sessa, A du Bois, J Ledermann, WG McCluggage, I McNeish, H Abdel Mageed, K Van Der Speeten, P Sugarbaker, N Ahmed, R Escalona, D Leung, E Chan, G Kannourakis, W Chowanadisai, SM Messerli, DH Miller, JE Medina, JW Hamilton, MA Messerli, AM Haslehurst, M Koti, M Dharsee, P Nuin, K Evans, J Geraci, P Ghosh, C Vidal, S Dey, L Zhang, LF Dong, J Neuzil, HD Osiewacz, M Huang, CR Myers, Y Wang, M You, SE Weinberg, NS Chandel, O WARBURG, DC Wallace, RM Pascale, DF Calvisi, MM Simile, CF Feo, F Feo, G Kroemer, L Galluzzi, C Brenner, N Joza, E Tasdemir, MC Maiuri, M Hengartner, JM Abrams, Y Ding, V Labitzky, K Legler, M Qi, U Schumacher, B Schmalfeldt, L Oliveira-Ferrer, J Dietl, C Bartmann, C Stürken, J Ghulam, C Stuerken, D Wicklein, R Pries, B Wollenberg, M Metzen, M Bruns, W Deppert, N Lüders, E Adam, DJ Flavell, D Boehm, SA Brooks, AJ Leathem, E Hjerpe, S Egyhazi, J Carlson, MF Stolt, K Schedvins, H Johansson, J Guo, X Li, W Zhang, S Zhu, L Chen, S Fulda, L Bockelmann, C Starzonek, AC Niehoff, U Karst, J Thomale, H Schluter, LC Bockelmann, WX Zong, JD Rabinowitz, E White, R Moreno-Sánchez, S Rodríguez-Enríquez, A Marín-Hernández, E Saavedra, Y Kubo, K Tanaka, Y Masuike, T Takahashi, K Yamashita, T Makino, CT Hensley, B Faubert, Q Yuan, N Lev-Cohain, E Jin, J Kim, LA Moukarzel, L Ferrando, H Dopeso, A Stylianou, T Basili, F Pareja, RJ DeBerardinis, JJ Lum, G Hatzivassiliou, CB Thompson, S Dar, J Chhina, I Mert, D Chitale, T Buekers, H Kaur, VW Liu, WC Xue, AN Cheung, HY Ngan, HY Lim, QS Ho, J Low, M Choolani, KP Wong, F Vazquez, JH Lim, H Chim, K Bhalla, G Girnun, K Pierce, EM Kuntz, P Baquero, AM Michie, K Dunn, S Tardito, TL Holyoake, DR Hodge, EM Hurt, WL Farrar, DS Matassa, MR Amoroso, H Lu, R Avolio, D Arzeni, C Procaccini, M Peiris-Pagès, UE Martinez-Outschoorn, RG Pestell, F Sotgia, MP Lisanti, AS Anderson, PC Roberts, MI Frisard, MW Hulver, EM Schmelz Show less
Most cancer patients ultimately die from the consequences of distant metastases. As metastasis formation consumes energy mitochondria play an important role during this process as they are the most im Show more
Most cancer patients ultimately die from the consequences of distant metastases. As metastasis formation consumes energy mitochondria play an important role during this process as they are the most important cellular organelle to synthesise the energy rich substrate ATP, which provides the necessary energy to enable distant metastasis formation. However, mitochondria are also important for the execution of apoptosis, a process which limits metastasis formation. We therefore wanted to investigate the mitochondrial content in ovarian cancer cells and link its presence to the patient’s prognosis in order to analyse which of the two opposing functions of mitochondria dominates during the malignant progression of ovarian cancer. Monoclonal antibodies directed against different mitochondrial specific proteins, namely heat shock proteins 60 (HSP60), fumarase and succinic dehydrogenase, were used in immunohistochemistry in preliminary experiments to identify the antibody most suited to detect mitochondria in ovarian cancer cells in clinical tissue samples. The clearest staining pattern, which even delineated individual mitochondria, was seen with the anti-HSP60 antibody, which was used for the subsequent clinical study staining primary ovarian cancers ( n  = 155), borderline tumours ( n  = 24) and recurrent ovarian cancers ( n  = 26). The staining results were semi-quantitatively scored into three groups according to their mitochondrial content: low ( n  = 26), intermediate ( n  = 50) and high ( n  = 84). Survival analysis showed that high mitochondrial content correlated with a statistically significant overall reduced survival rate In addition to the clinical tissue samples, mitochondrial content was analysed in ovarian cancer cells grown in vitro (cell lines: OVCAR8, SKOV3, OVCAR3 and COV644) and in vivo in severe combined immunodeficiency (SCID) mice. In in vivo grown SKOV3 and OVCAR8 cells, the number of mitochondria positive cells was markedly down-regulated compared to the in vitro grown cells indicating that mitochondrial number is subject to regulatory processes. As high mitochondrial content is associated with a poor prognosis, the provision of high energy substrates by the mitochondria seems to be more important for metastasis formation than the inhibition of apoptotic cell death, which is also mediated by mitochondria. In vivo and in vitro grown human ovarian cancer cells showed that the mitochondrial content is highly adaptable to the growth condition of the cancer cells. Show less
đź“„ PDF DOI: 10.1186/s12885-023-11667-8
mitochondria
Saverio Tardito, Irene Bassanetti, Chiara Bignardi +6 more · 2011 · Journal of the American Chemical Society · ACS Publications · added 2026-04-20
We report a quantitative structure-activity relationship study of a new class of pyrazole-pyridine copper complexes that establishes a clear correlation between the ability to promote copper accumulat Show more
We report a quantitative structure-activity relationship study of a new class of pyrazole-pyridine copper complexes that establishes a clear correlation between the ability to promote copper accumulation and cytotoxicity. Intracellular metal accumulation is maximized when ligand lipophilicity allows the complex to rapidly cross the membrane. Copper and ligand follow different uptake kinetics and reach different intracellular equilibrium concentrations. These results support a model in which the ligand acts as an ionophore for the metal ion, cycling between intra- and extracellular compartments as dissociated or complexed entities. When treating cancer cells with structurally unrelated disulfiram and pyrazole-pyridine copper complexes, as well as with inorganic copper, the same morphological and molecular changes were reproduced, indicating that copper overload is responsible for the cytotoxic effects. Copper-based treatments drive sensitive cancer cells toward paraptotic cell death, a process hallmarked by endoplasmic reticulum stress and massive vacuolization in the absence of apoptotic features. A lack of caspase activation, as observed in copper-treated dying cells, is a consequence of metal-mediated inhibition of caspase-3. Thus, copper acts simultaneously as an endoplasmic reticulum (ER) stress inducer and a caspase-3 inhibitor, forcing the cell into caspase-independent paraptotic death. The establishment of a mechanism of action common to different copper binding agents provides a rationale for the exploitation of copper toxicity as an anticancer tool. Show less
no PDF DOI: 10.1021/ja109413c
Cu